U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06855992) titled 'Transcutaneous Laser Therapy in Chronic Kidney Disease' on Feb. 21.
Brief Summary: Chronic kidney disease (CKD) affects approximately 10% of the global population, totaling over 800 million people. In Taiwan, one in eight individuals is diagnosed with CKD. According to National Health Insurance data, acute kidney injury and CKD rank first in medical expenditures, imposing a significant burden on patients' quality of life and the national healthcare system. Early intervention in CKD, especially for high-risk populations (e.g., individuals with diabetes or early-stage kidney dysfunction), can slow disease progression, delay the onset ...